| 2001 |
Yeast Coq4p peripherally associates with the matrix face of the mitochondrial inner membrane, is imported via a mitochondrial targeting sequence in a membrane-potential-dependent manner, and its presence is required to maintain steady-state levels of Coq7p, another CoQ biosynthetic component. |
Western blot with specific antiserum, subcellular fractionation, in vitro mitochondrial import assay |
Archives of biochemistry and biophysics |
Medium |
11469793
|
| 2008 |
Yeast Coq4p organizes a high-molecular-mass multi-enzyme complex required for CoQ biosynthesis; coq4 point mutants (E226K and E121K) disrupt co-migration of Coq3p, Coq4p, and Coq7p in this complex as shown by Blue Native-PAGE and gel filtration, without reducing steady-state levels of Coq polypeptides. |
Blue Native PAGE (1D and 2D), gel filtration chromatography, O-methyltransferase activity assay on digitonin-solubilized mitochondrial extracts |
Biochimica et biophysica acta |
High |
19022396
|
| 2008 |
Human COQ4 isoform 1 (265 aa) contains a functional N-terminal mitochondrial targeting sequence and localizes to mitochondria; isoform 2 (241 aa), lacking this sequence, does not localize to mitochondria. Human COQ4 isoform 1 complements COQ4-null yeast, restoring growth on non-fermentable carbon and CoQ content. |
GFP-fusion protein live imaging in HeLa cells; functional complementation of COQ4-null yeast |
Biochemical and biophysical research communications |
High |
18474229
|
| 2012 |
Haploinsufficiency of COQ4 (48% expression) reduces CoQ10 content and biosynthetic rate (~43–44% of controls) and impairs respiratory chain complex II+III activity in patient fibroblasts; knockdown of COQ4 in HeLa cells similarly reduces CoQ10. Unlike other CoQ biosynthesis genes, haploinsufficiency of COQ4 alone is sufficient to cause CoQ deficiency. |
Biochemical assay of CoQ10 content and biosynthetic rate; respiratory chain enzyme activity assay in patient fibroblasts; siRNA knockdown in HeLa cells; yeast haploinsufficiency model |
Journal of medical genetics |
High |
22368301
|
| 2015 |
COQ4 plays a structural role stabilizing a multiheteromeric complex containing most CoQ10 biosynthetic enzymes; pathogenic human COQ4 mutations fail to complement COQ4-null yeast for oxidative growth, whereas wild-type human COQ4 cDNA fully rescues growth, demonstrating loss-of-function pathogenicity. |
Yeast complementation assay (oxidative growth rescue); reduced CoQ10 and CoQ10-dependent ETC activities measured in patient specimens |
American journal of human genetics |
High |
25658047
|
| 2021 |
COQ4-deficient patient fibroblasts show elevated levels of the metabolic intermediate 6-demethoxyubiquinone alongside reduced CoQ10 and reduced COQ4 protein, placing COQ4 activity at the step converting 6-demethoxyubiquinone to downstream CoQ precursors. |
Biochemical assay of CoQ10 and 6-demethoxyubiquinone in patient-derived fibroblasts; Western blot for COQ4 protein levels |
Journal of medical genetics |
Medium |
34656997
|
| 2021 |
Coq4 loss-of-function in zebrafish (coq4 F0 CRISPR crispants) causes motor defects and cell reduction in a specific hindbrain region analogous to the human cerebellum, demonstrating an in vivo developmental role for COQ4 in brain formation. |
CRISPR F0 zebrafish crispant generation; behavioral motor assay; histological analysis of hindbrain |
Journal of neurology |
Medium |
33704555
|
| 2024 |
COQ4 catalyzes the oxidative decarboxylation of the C1 carbon of CoQ precursors in eukaryotes; it complements an E. coli strain deficient for C1 decarboxylation/hydroxylation and displays oxidative decarboxylation activity in the non-CoQ-producing organism Corynebacterium glutamicum, demonstrating that COQ4 has a direct enzymatic (not merely structural) function in CoQ biosynthesis. |
Heterologous complementation assay in E. coli deficient for C1 decarboxylation/hydroxylation; functional activity assay in Corynebacterium glutamicum; CoQ precursor metabolite analysis |
Molecular cell |
High |
38295803
|
| 2023 |
COQ4 loss-of-function in patient-derived fibroblasts and COQ4 knockout complementation cell lines causes mitochondrial reactive oxygen species accumulation, decreased mitochondrial membrane potential, and reduced ubiquinone biosynthesis; coq4 knockdown in zebrafish causes severe motor dysfunction reflecting motor neuron dysregulation. |
ROS assay, mitochondrial membrane potential measurement, ubiquinone quantification in patient fibroblasts and knockout complementation lines; coq4 zebrafish knockdown with motor behavioral assay |
Movement disorders : official journal of the Movement Disorder Society |
Medium |
38014483
|
| 2026 |
Coq4 deficiency disrupts placental vascular development through the FSP1/CoQ10 antioxidant axis; Coq4-/- embryos are lethal and show placental vascular rarefaction and impaired trophoblast invasion. Coq4 knockdown in HUVECs upregulates ferroptosis markers (ACSL4, FTH1) and downregulates FSP1, and FSP1 overexpression or CoQ10 supplementation partially alleviates ferroptosis. |
CRISPR-Cas9 Coq4+/- and Coq4-/- mouse generation; placental histology and immunofluorescence; lentiviral Coq4 knockdown in HUVECs; RNA-seq; Western blot for ferroptosis pathway proteins; rescue experiments with FSP1 overexpression and CoQ10 supplementation |
Frontiers in cell and developmental biology |
Medium |
41847387
|